CeADAR, Ireland’s centre for artificial intelligence, is helping to develop a new diagnostics system for the detection and monitoring of Alzheimer’s Disease.
The €6m 2D-BioPad project is being undertaken by 11 public and private institutions from across Europe with the aim of developing a point-of-care (PoC) diagnostics system capable of detecting the early signs of Alzheimer’s more quickly, cheaply and reliably and less invasively than existing tools and procedures.
Researchers aim to leverage previous studies into the unique properties of graphene, a material consisting of a single layer of atoms that is stronger than most steels and has more thermal and electrical conductivity than copper.
They hope that a graphene-based PoC diagnostics system will combine nano and DNA technologies to analyse patients’ blood samples and identify and quantify up to five biomarkers for AD.
CeADAR is leading the training and optimisation of the AImodels to be used in the identification of …